Hepquant, Llc
Clinical trials sponsored by Hepquant, Llc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New test could spot liver trouble early in fontan patients Results expected Dec 2026 (estimated)
- New blood test method for liver disease could make diagnosis easier Results expected Feb 2027 (estimated)
-
A blood test could map how the liver heals after alcohol damage
Diagnosis Recruiting nowResearchers are studying whether a blood test called HepQuant DuO can measure liver function over time in people with alcohol-related liver disease. Participants drink a natural compound called cholate, then give two blood samples at 20 and 60 minutes. The study follows about 40 …
Sponsor: HepQuant, LLC • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
New test could spot liver trouble early in fontan patients
Knowledge-focused Recruiting nowThis study is testing a new way to measure liver function in adults who have had the Fontan procedure, a surgery for certain heart defects. Researchers will use a dual cholate clearance test (a special blood test) and a heart MRI to see how well the liver is working. They will co…
Sponsor: HepQuant, LLC • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC